Case StudiesA targeted approach to complex wounds: a case study evaluation

A targeted approach to complex wounds: a case study evaluation

Complex wounds, Diabetic foot ulcers, Infection, Leg Ulcers

A targeted approach to complex wounds: a case study evaluationAlthough delayed healing appears to be common, it is frequently not recognised at an early stage and can pose a major problem. The early detection of key factors responsible for delayed healing (eg infection and elevated protease activity) and management using targeted interventions has been shown to result in a reduction in overall treatment duration, resource use and costs.

This document contains a number of case studies in patients with a range of complex wounds where healing may have been delayed due to infection and/or elevated protease activity (EPA).

 

 

 

 

These case studies evaluate the use of the following dressings:

  • SILVERCEL® NON-ADHERENT
  • ACTISORB® SILVER 220
  • PROMOGRAN® AND PROMOGRAN PRISMA®

The key outcomes included:

  • Wounds treated with silver dressings showed a marked improvement in signs of infection with a reduction in exudate levels, elimination of odour and pain, and improvement in the condition of the wound bed by week 4
  • Wounds with detected EPA and treated with protease modulating therapy showed evidence of healing at 2 weeks and low protease levels by week 4
  • All wounds progressed over 4 weeks using a targeted approach to treatment.

This document was produced in association with Systagenix